A method for preparing theaflavin derivatives

By introducing hexaphenol-based intertriphenyl structure in theophane synthesis and using plant-source PPO and immobilized carriers, the problem of insufficient antioxidant capacity of theophane is solved, significantly improving its free radical scavenging ability and process efficiency, and achieving more Highly efficient antioxidant properties.

CN116003367BActive Publication Date: 2024-11-22XINHUA COUNTY HOLY-TEA LTD CO
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211632861.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-12-19
Publication Date
2024-11-22
Estimated Expiration
2042-12-19

AI Technical Summary

Technical Problem

The existing theaflavin synthesis methods are difficult to improve their antioxidant ability, especially after the introduction of new structural modifications, theaflavin's free radical scavenging ability is insufficient.

Method used

By introducing hexaphenol-based intertriphenyl structure from epigallocate gallate, and using plant-source polyphenol oxidase (PPO) for enzymatic oxidation, combined with aminolated mesoporous silica as an immobilization carrier, it was prepared Theaflavin derivatives with higher activity, pH tolerance and thermal stability.

Benefits of technology

The DPPH radical scavenging ability of theaflavin is significantly improved, its antioxidant performance is improved, the reaction yield is high, and the plant-source PPO and immobilized carrier are used, which improves the efficiency of the process and the stability of the product.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDA0004889939180000011
    Figure FDA0004889939180000011
  • Figure FDA0004889939180000012
    Figure FDA0004889939180000012
  • Figure FDA0004889939180000021
    Figure FDA0004889939180000021
Patent Text Reader

Abstract

The invention relates to the field of organic synthesis, in particular to a method for preparing a theaflavin derivative, comprising the following steps: protecting the hydroxyl group on epigallocatechin gallate to obtain an intermediate A; hydrolyzing the ester bond of the intermediate A to obtain an intermediate B; introducing a hexaphenol-based meta-terphenyl structure into the intermediate B to obtain an intermediate C; deprotecting the intermediate C to obtain an intermediate D; and reacting the intermediate D with catechin under PPO catalysis to obtain the theaflavin derivative. Compared with the theaflavin, the theaflavin derivative prepared by the invention has a greatly improved DPPH free radical scavenging ability.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of organic synthesis, and in particular to a method for preparing a theaflavin derivative. Background Art

[0002] Theaflavins are produced by oxidative coupling of different catechin monomers under the action of polyphenol oxidase or peroxidase. They are a class of polyphenol compounds with a benzophenone structure and are the main active ingredient in tea that exerts its health benefits.

[0003] At present, 28 theaflavins have been discovered and identified, among which theaflavins (TF1), theaflavins-3-gallate (TF2A), theaflavins-3'-gallate (TF2B), and theaflavins-3,3'-digallate (TF3) are the four most important theaflavins. Theaflavins have anti-tumor, anti-inflammatory, antioxidant, anti-viral, anti-bacterial and anti-proliferative effects, and are a class of natural products with great development potential. Structural modification of theaflavins to obtain theaflavins derivatives with more functions has become the current research focus. Summary of the invention

[0004] Purpose of the invention: In view of the above technical trends, the present invention proposes a method for preparing theaflavin derivatives.

[0005] The technical solutions adopted are as follows:

[0006] A method for preparing a theaflavin derivative comprises the following steps:

[0007] ;

[0008] S1: Protect the hydroxyl group on epigallocatechin gallate to obtain intermediate A;

[0009] ;

[0010] S2: hydrolyzing the ester bond of intermediate A to obtain intermediate B;

[0011] ;

[0012] S3: introducing a hexaphenol-based meta-terphenyl structure into intermediate B to obtain intermediate C;

[0013] ;

[0014] S4: deprotecting intermediate C to obtain intermediate D;

[0015] ;

[0016] S5: The intermediate D reacts with catechin under the catalysis of PPO to obtain the theaflavins derivative.

[0017] Further, S1 is as follows:

[0018] Under a protective gas atmosphere, epigallocatechin gallate was dissolved in DMF, and then benzyl bromide and potassium carbonate were added, and the mixture was stirred at 60-80° C. for 3-5 h. The reaction product was purified to obtain intermediate A.

[0019] Further, S2 is as follows:

[0020] The intermediate A is dissolved in DMF, sodium hydroxide is added, and the temperature is raised to reflux for reaction for 3-8 hours. The reaction product is purified to obtain the intermediate B.

[0021] Further, S3 is as follows:

[0022] Add intermediate B and 3,3'',4,4',5,5''-hexahydroxy-[1,1':3',1''-triphenyl]-5'-carboxylic acid to DMF, use concentrated sulfuric acid as a catalyst, heat to 70-90°C for reaction for 5-10 hours, and then concentrate under reduced pressure to remove the solvent. Add ethyl acetate and water for extraction and separation, and purify by ethyl acetate phase column chromatography to obtain intermediate C.

[0023] Further, S4 is as follows:

[0024] Add intermediate C and acetic acid to methanol, add platinum-carbon catalyst, introduce hydrogen and heat to 60-65°C to react for 8-15 hours. After the reaction is completed, cool to room temperature, filter, and concentrate the filtrate under reduced pressure to remove the solvent. Add ethyl acetate and water to extract and separate the liquids, and purify by ethyl acetate column chromatography to obtain intermediate D.

[0025] Further, S5 is as follows:

[0026] The intermediate D and catechins are added to a citric acid-disodium hydrogen phosphate buffer solution, ethanol is added to help dissolution, and after shaking for 30-50 minutes, PPO is added, shaken, and reacted at 30-40° C. for 2-5 hours with intermittent shaking. After the reaction is completed, centrifuge, take the supernatant, concentrate under reduced pressure to remove ethanol, extract with ethyl acetate, and purify by column chromatography to obtain the theaflavins derivative.

[0027] Furthermore, the PPO is extracted from pears, preferably Qiuyue pears.

[0028] Furthermore, the preparation method of the PPO is as follows:

[0029] Chop Qiuyue pear into pieces, add to disodium hydrogen phosphate-citric acid buffer, mash and homogenize, extract at 2-5℃ for 10-15h, centrifuge to obtain the supernatant, add the immobilized carrier, stir and adsorb at 30-40℃ for 3-5h, then filter, wash the obtained solid with disodium hydrogen phosphate-citric acid buffer and then freeze-dry it in vacuum.

[0030] Furthermore, the immobilization carrier is amino-modified mesoporous silica.

[0031] Furthermore, the preparation method of the amino-modified mesoporous silica is as follows:

[0032] Mix hexadecyltrimethylammonium bromide, sodium cocoyl glycinate and water, stir evenly, add sulfuric acid, continue stirring for 50-80 minutes, then drop ethyl orthosilicate, stir for 24-48 hours after dropping, add ammonia water, stir for 1-5 minutes, heat to 75-85℃ and age for 24-48 hours, separate the solid, wash with water, dry, then heat to 580-660℃ and calcine for 3-5 hours, add the calcined product to anhydrous toluene, add aminopropyltriethoxysilane, stir evenly, heat to reflux reaction for 10-15 hours, wash the reaction product and dry.

[0033] Beneficial effects of the present invention:

[0034] The in vitro enzymatic synthesis process of theaflavins is relatively mature. The inventors introduced a hexaphenol-based terphenyl structure starting from epigallocatechin gallate. The obtained theaflavins derivatives have a greatly improved ability to scavenge DPPH free radicals compared to theaflavins. PPO is widely present in fresh tea leaves and other plants and microorganisms. The inventors used an in vitro simulated oxidation system to perform enzymatic oxidation with plant-derived PPO, and prepared immobilized PPO using amino-modified mesoporous silica as an immobilization carrier, so that it has higher activity, pH tolerance and thermal stability, and has a higher reaction yield. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 The figure is a process map for preparing theaflavin derivatives in Example 1 of the present invention. DETAILED DESCRIPTION

[0036] If the specific conditions are not specified in the examples, the experiments were carried out under conventional conditions or the conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments is not specified, they are all conventional products that can be purchased commercially. The technologies not mentioned in the present invention are all referenced to the prior art.

[0037] Embodiment 1:

[0038] A method for preparing theaflavin derivatives:

[0039] ;

[0040] S1: Under nitrogen protection, 45.8 g of epigallocatechin gallate was dissolved in 500 mL of DMF, and then 171 g of benzyl bromide and 110 g of potassium carbonate were added. The temperature was raised to 60-80 °C and stirred for reaction for 3-5 h. After the reaction solution was cooled to room temperature, silica gel was added for column chromatography (petroleum ether: ethyl acetate: methanol = 5:2:1) to obtain intermediate A with a yield of 53.5%;

[0041] ;

[0042] S2: Dissolve 50 g of intermediate A in 500 mL of DMF, add 8.5 g of sodium hydroxide, heat to reflux and react for 3-8 hours. After the reaction solution is cooled to room temperature, add silica gel column chromatography (petroleum ether: ethyl acetate: methanol = 5:2:1) to obtain intermediate B with a yield of 80.3%;

[0043] ;

[0044] S3: 20 g of intermediate B and 7.2 g of 3,3'', 4,4', 5,5''-hexahydroxy-[1,1':3',1''-triphenyl]-5'-carboxylic acid were added to 200 mL of DMF, and 5 mL of concentrated sulfuric acid was added as a catalyst. The temperature was raised to 70-90°C for reaction for 5-10 hours, and then the solvent was removed by concentration under reduced pressure. Ethyl acetate and water were added for extraction and separation, and the ethyl acetate phase was added to silica gel column chromatography (petroleum ether: ethyl acetate: methanol = 2:1:1) to obtain intermediate C with a yield of 37.2%;

[0045] ;

[0046] S4: Add 200 mL of methanol to the hydrogenation reactor, then add 10 g of intermediate C, 60 mL of acetic acid, and 1 g of platinum-carbon catalyst, first replace the air with nitrogen and then replace the nitrogen with hydrogen, maintain the hydrogen atmosphere, heat to 65 ° C for 8-15 hours, cool to room temperature after the reaction, filter, and concentrate the filtrate under reduced pressure to remove the solvent. After extraction and separation with ethyl acetate and water, take the ethyl acetate phase and add silica gel column chromatography (ethyl acetate: methanol = 1:2) to obtain intermediate D with a yield of 85.5%;

[0047] ;

[0048] S5: Mix hexadecyltrimethylammonium bromide, sodium cocoyl glycinate, and 670 mL of water, stir evenly, add 5 mL of concentrated sulfuric acid, continue stirring for 50-80 min, then drop 33.5 mL of ethyl orthosilicate, stir for 24-48 h after the dropwise addition, add 150 mL of ammonia water, stir for 1-5 min, heat to 75-85 ° C, age for 24-48, separate the solid, wash with water, dry, and heat to 580-660 ° C for calcination for 3-5 h, add 5 times the mass of the calcined product to anhydrous toluene, add aminopropyl triethoxysilane (the mass ratio of aminopropyl triethoxysilane to the calcined product is 1:1), stir evenly, and heat to reflux. The reaction was carried out for 10-15 hours. The reaction product was washed and dried to obtain amino mesoporous silica. 10 g of Qiuyue pear was chopped and added to 100 mL of disodium hydrogen phosphate-citric acid buffer solution. The slurry was crushed and extracted at 2-5 ° C for 10-15 hours. The supernatant was centrifuged and 5 g of amino mesoporous silica was added. After stirring and adsorbing at 30-40 ° C for 3-5 hours, the supernatant was filtered. The obtained solid was washed with disodium hydrogen phosphate-citric acid buffer solution and then vacuum freeze-dried to obtain PPO. 1.3 g of intermediate D and 0.87 g of catechin were added to 10 mL of citric acid-disodium hydrogen phosphate buffer solution, 5 mL of ethanol was added to help dissolve, and after shaking for 30-50 minutes, 1 g of PPO, shake well, react at 30-40℃ for 2-5h, shake intermittently during the reaction, centrifuge after the reaction, take the supernatant, concentrate under reduced pressure to remove ethanol, extract with ethyl acetate, add silica gel mixing column chromatography (ethyl acetate: methanol = 1:2) to obtain theaflavin derivatives with a yield of 45.7% and a purity of 95.5%.

[0049] Comparative Example 1: It is basically the same as Example 1, except that commercially available mesoporous silica (Beijing Zhongke Keyou Technology) is used in S5 instead of the prepared amino-modified mesoporous silica. The yield of S5 is 30.6% and the purity is 94.3%.

[0050] Comparative Example 2: basically the same as Example 1, except that the calcined product in S5 is not treated with aminopropyltriethoxysilane, and the yield of S5 is 33.2% and the purity is 94.8%.

[0051] Performance test: DPPH is a very stable nitrogen-centered free radical that is dark purple in solution and has strong absorption at 517nm. In the antioxidant test, antioxidants can directly remove DPPH. As the free radical decreases, the color of the solution gradually changes from dark purple to colorless. Therefore, the antioxidant capacity of the antioxidant can be calculated by the change in absorbance.

[0052] Preparation of DPPH mother solution: accurately weigh 7.2 mg DPPH and dissolve it in 25 ml methanol. Store it at -20°C and avoid light. Before use, take a small amount of the mother solution and dilute it 5 times to obtain the DPPH working solution. Detect the absorbance at 517 nm (A 前);

[0053] The theaflavins derivatives prepared in Example 1 and Comparative Examples 1-2 and commercially available theaflavins were dissolved in methanol to a concentration of 0.01 μmol·mL -1 100 μL of the working solution was added to 100 μL of DPPH working solution and then shaken to mix. The mixture was protected from light and reacted at room temperature for 20 min. The absorbance (A) was measured at 517 nm. 后 );

[0054] DPPH free radical scavenging rate (%) = [(A 前 -A 后 ) / A 前 ]*100%

[0055] The test results are shown in Table 1 below:

[0056] Table 1:

[0057] ;

[0058] It can be seen from the above tests that the theaflavins derivatives prepared in the present invention have a significantly improved DPPH free radical scavenging ability compared to theaflavins.

[0059] The above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit the same. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for preparing a theaflavin derivative, characterized in that: The following steps are involved: S1: Protect the hydroxyl group on epigallocatechin gallate to obtain intermediate A; S2: hydrolyzing the ester bond of intermediate A to obtain intermediate B; S3: introducing a hexaphenol-based meta-terphenyl structure into intermediate B to obtain intermediate C; S4: deprotecting intermediate C to obtain intermediate D; S5: The intermediate D reacts with catechin under the catalysis of PPO to obtain the theaflavins derivative.

2. The method for preparing theaflavin derivatives according to claim 1, characterized in that: S1 is as follows: Under a protective gas atmosphere, epigallocatechin gallate was dissolved in DMF, and then benzyl bromide and potassium carbonate were added, and the mixture was stirred at 60-80° C. for 3-5 h. The reaction product was purified to obtain intermediate A.

3. The method for preparing theaflavin derivatives according to claim 1, characterized in that: S2 is as follows: The intermediate A is dissolved in DMF, sodium hydroxide is added, and the temperature is raised to reflux for reaction for 3-8 hours. The reaction product is purified to obtain the intermediate B.

4. The method for preparing theaflavin derivatives according to claim 1, characterized in that: S3 is as follows: Add intermediate B and 3,3", 4,4', 5,5"-hexahydroxy-[1,1':3',1"-triphenyl]-5'-carboxylic acid to DMF, use concentrated sulfuric acid as a catalyst, heat to 70-90°C for reaction for 5-10 hours, and then concentrate under reduced pressure to remove the solvent. Add ethyl acetate and water for extraction and separation, and purify by ethyl acetate phase column chromatography to obtain intermediate C.

5. The method for preparing theaflavin derivatives according to claim 1, characterized in that: S4 is as follows: Add intermediate C and acetic acid to methanol, add platinum-carbon catalyst, introduce hydrogen and heat to 60-65°C to react for 8-15 hours. After the reaction is completed, cool to room temperature, filter, and concentrate the filtrate under reduced pressure to remove the solvent. Add ethyl acetate and water to extract and separate the liquids, and purify by ethyl acetate column chromatography to obtain intermediate D.

6. The method for preparing theaflavin derivatives according to claim 1, characterized in that: S5 is as follows: The intermediate D and catechins are added to a citric acid-disodium hydrogen phosphate buffer solution, ethanol is added to help dissolution, and after shaking for 30-50 minutes, PPO is added, shaken, and reacted at 30-40° C. for 2-5 hours with intermittent shaking. After the reaction is completed, centrifuge, take the supernatant, concentrate under reduced pressure to remove ethanol, extract with ethyl acetate, and purify by column chromatography to obtain the theaflavins derivative.

7. The method for preparing theaflavin derivatives according to claim 1, characterized in that: The PPO is extracted from pears.

8. The method for preparing theaflavin derivatives according to claim 7, characterized in that: The preparation method of the PPO is as follows: Chop Qiuyue pear into pieces, add to disodium hydrogen phosphate-citric acid buffer, mash and homogenize, extract at 2-5℃ for 10-15h, centrifuge to obtain the supernatant, add the immobilized carrier, stir and adsorb at 30-40℃ for 3-5h, then filter, wash the obtained solid with disodium hydrogen phosphate-citric acid buffer and then freeze-dry it in vacuum.

9. The method for preparing theaflavin derivatives according to claim 8, characterized in that: The immobilization carrier is amino-modified mesoporous silica.

10. The method for preparing theaflavin derivatives according to claim 9, characterized in that: The preparation method of the amino mesoporous silica is as follows: Mix hexadecyltrimethylammonium bromide, sodium cocoyl glycinate and water, stir evenly, add sulfuric acid, continue stirring for 50-80 minutes, then drop ethyl orthosilicate, stir for 24-48 hours after dropping, add ammonia water, stir for 1-5 minutes, heat to 75-85℃ and age for 24-48 hours, separate the solid, wash with water, dry, then heat to 580-660℃ and calcine for 3-5 hours, add the calcined product to anhydrous toluene, add aminopropyltriethoxysilane, stir evenly, heat to reflux reaction for 10-15 hours, wash the reaction product and dry.